QuickView for MAPK1;jsessionid=CEE42355B31D8C288D6C5C69ABD395FA;jsessionid=8770070DB02F93EA8DFD31DFEB7CD106;jsessionid=5D543D729715F06C8006DB168FEBCB11;jsessionid=7A216D89B4BDE632EC29BA25F35D0941;jsessionid=3E938E8F20FE350E068A7E09CF96C62B (gene)

1. Distinct binding modes of a benzothiazole derivative confer structural bases for increasing ERK2 or …
2. Low entropic cost of binding confers high selectivity on an allosteric ERK2 inhibitor.
3. Targeting MAPK in Cancer 2.0.
4. MAPK signaling pathway orchestrates and fine-tunes the pathogenicity of Colletotrichum falcatum.
5. MAPK-Activated Protein Kinases: Servant or Partner?

There were no clinical trials for MAPK1;jsessionid=CEE42355B31D8C288D6C5C69ABD395FA;jsessionid=8770070DB02F93EA8DFD31DFEB7CD106;jsessionid=5D543D729715F06C8006DB168FEBCB11;jsessionid=7A216D89B4BDE632EC29BA25F35D0941;jsessionid=3E938E8F20FE350E068A7E09CF96C62B